Rapid method for the quantitative determination of efavirenz in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 5, 2009, Pages 1308-1312

  Mogatle, Seloi ^a   Kanfer, Isadore ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

Cost effective; Efavirenz; HPLC UV; Human plasma; Rapid

Indexed keywords

DICLOFENAC; EFAVIRENZ;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

BENZOXAZINES; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FREEZING; HUMANS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE INHIBITORS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE; TIME FACTORS;

EID: 67349133129     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.03.008     Document Type: Article

References (30)

1. Young S.D., Britcher S.F., Tran L.O., Payne L.S., Lumma W.C., Lyle T.A., Huff J.R., Anderson P.S., Olsen D.B., Carroll S.S., Pettibone D.J., O'Brien J.A., Ball R.G., Balani S.K., Lin J.H., Chen I., Schleif W.A., Sardana V.V., and Long W.J. Antimicrob. Agents Chemother. 39 (1995) 2602-2605
2. Bristol Myers Squibb Company. SUSTIVA package insert (2008).
3. Barrett J.S., Joshi A.S., Chai M., Ludden T.M., Fiske W.D., and Pieniaszek Jr. H.J. Int. J. Clin. Pharmacol. Therap. 40 (2002) 507-519
4. Csajka C., Marzolini C., Fattinger K., Décosterd L.A., Fellay J., Telenti A., Biollaz J., and Buclin T. Clin. Pharmacol. Therap. 73 (2003) 20-30
5. Burger D., van der Heiden I., la Porte C., van der Ende M., Groeneveld P., Richter C., Koopmans P., Kroon F., Sprenger H., Lindemans J., Schenk P., and van Schaik R. Br. J. Clin. Pharmacol. 61 (2006) 148-154
6. Ståhle L., Moberg L., Svensson J.-O., and Sönnerborg A. Therap. Drug Monit. 26 (2004) 267-270
7. Aymard G., Legrand M., Trichereau N., and Diquet B. J. Chromatogr. B: Biomed. Sci. Appl. 744 (2000) 227-240
8. Choi S.O., Rezk N.L., and Kashuba A.D.M. J. Pharm. Biomed. Anal. 43 (2007) 1562-1567
9. Kappelhoff B.S., Rosing H., Huitema A.D.R., and Beijnen J.H. J. Chromatogr. B 792 (2003) 353-362
10. Lakshmi S.A., Kishore K.K., Ravi K.D.V.R., Mohan K.C., Yugandhar N.M., and Srinubabu G. Chromatographia 65 (2007) 359-361
11. Langmann P., Schirmer D., Vath T., Zilly M., and Klinker H. J. Chromatogr. B: Biomed. Sci. Appl. 755 (2001) 151-156
12. Marzolini C., Telenti A., Buclin T., Biollaz J., and Decosterd L.A. J. Chromatogr. B: Biomed. Sci. Appl. 740 (2000) 43-58
13. Notari S., Bocedi A., Ippolito G., Narciso P., Pucillo L.P., Tossini G., Donnorso R.P., Gasparrini F., and Ascenzi P. J. Chromatogr. B 831 (2006) 258-266
14. Ramachandran G., Kumar A.K.H., Swaminathan S., Venkatesan P., Kumaraswami V., and Greenblatt D.J. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 835 (2006) 131-135
15. Rezk N.L., Tidwell R.R., and Kashuba A.D.M. J. Chromatogr. B 805 (2004) 241-247
16. Sarasa-Nacenta M., López-Púa Y., López-Cortés L.F., Mallolas J., Gatell J.M., and Carné X. J. Chromatogr. B: Biomed. Sci. Appl. 763 (2001) 53-59
17. Simon V.A., Thiam M.D., and Lipford L.C. J. Chromatogr. A 913 (2001) 447-453
18. Titier K., Lagrange F., Péhoureq F., Edno-McHeik L., Moore N., and Molimard M. Therap. Drug Monit. 24 (2002) 417-424
19. Turner M.L., Reed-Walker K., King J.R., and Acosta E.P. J. Chromatogr. B 784 (2003) 331-341
20. Usami Y., Oki T., Nakai M., Sagisaka M., and Kaneda T. Chem. Pharm. Bull. 51 (2003) 715-718
21. Veldkamp A.I., Van Heeswijk R.P.G., Meenhorst P.L., Mulder J.W., Lange J.M.A., Beijnen J.H., and Hoetelmans R.M.W. J. Chromatogr. B: Biomed. Sci. Appl. 734 (1999) 55-61
22. Villani P., Pregnolato M., Banfo S., Rettani M., Burroni D., Seminari E., Maserati R., and Regazzi M.B. Therap. Drug Monit. 21 (1999) 346-350
23. Weller D.R., Brundage R.C., Balfour J., Henry H., and Vezina H.E. J. Chromatogr. B 848 (2007) 369-373
24. Rouzes A., Berthoin K., Xuereb F., Djabarouti S., Pellegrin I., Pellegrin J.L., Coupet A.C., Augagneur S., Budzinski H., Saux M.C., and Breilh D. J. Chromatogr. B 813 (2004) 209-216
25. Matthews C.Z., Woolf E.J., Mazenko R.S., Haddix-Wiener H., Chavez-Eng C.M., Constanzer M.L., Doss G.A., and Matuszewski B.K. J. Pharm. Biomed. Anal. 28 (2002) 925-934
26. Pereira E.A., Micke G.A., and Tavares M.F.M. J. Chromatogr. A 1091 (2005) 169-176
27. U.S. Department of Health and Human Services. FDA. Guidance for Industry Bioanalytical Method Validaton (2001) http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm.
28. Trudnowski R.J., and Rico C.R. Clin. Chem. 20 (1974) 615-616
29. Nowatzke W., and Woolf E. AAPS J. 9 (2007) E117-E122
30. Mogatle S., and Kanfer I. SAMJ 98 (2008) 945-949